MBP and breast cancer: BBzP and DBP, parent compounds of MBzP and MBP, respectively (MBP is also a minor metabolite of BBzP), led to demethylation of estrogen receptor α promoter–associated CpG islands, producing a growth inhibitory effect on human MCF-7 BC cells (Kang and Lee 2005), thus reducing BC risk.